Male Hypogonadism in Systemic Disease

Rita R. Kalyani, Sravanya Gavini, Adrian S Dobs

Research output: Contribution to journalArticle

Abstract

Hypogonadism is often observed in the presence of common acute and chronic illnesses in men. Low testosterone levels in these patients can be associated with loss of lean body mass and bone mass density, decline in mood, loss of energy, and sexual dysfunction. The mechanisms explaining hypogonadism and various systemic diseases are not completely understood, but these conditions are likely caused by a combination of stress, nonspecific weight loss, inflammation, and medication. Testosterone replacement can be considered in this population to improve lean body mass, bone mass density, and quality of life. More information is needed regarding the risk benefits of testosterone treatment on health outcomes in men who have systemic illness.

Original languageEnglish (US)
Pages (from-to)333-348
Number of pages16
JournalEndocrinology and Metabolism Clinics of North America
Volume36
Issue number2
DOIs
StatePublished - Jun 2007

Fingerprint

Eunuchism
Testosterone
Hypogonadism
Bone Density
Bone
Weight Loss
Chronic Disease
Quality of Life
Health
Inflammation
Population
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Biochemistry

Cite this

Male Hypogonadism in Systemic Disease. / Kalyani, Rita R.; Gavini, Sravanya; Dobs, Adrian S.

In: Endocrinology and Metabolism Clinics of North America, Vol. 36, No. 2, 06.2007, p. 333-348.

Research output: Contribution to journalArticle

@article{b80305bbaedf4c0e921b0e5bef4bca3b,
title = "Male Hypogonadism in Systemic Disease",
abstract = "Hypogonadism is often observed in the presence of common acute and chronic illnesses in men. Low testosterone levels in these patients can be associated with loss of lean body mass and bone mass density, decline in mood, loss of energy, and sexual dysfunction. The mechanisms explaining hypogonadism and various systemic diseases are not completely understood, but these conditions are likely caused by a combination of stress, nonspecific weight loss, inflammation, and medication. Testosterone replacement can be considered in this population to improve lean body mass, bone mass density, and quality of life. More information is needed regarding the risk benefits of testosterone treatment on health outcomes in men who have systemic illness.",
author = "Kalyani, {Rita R.} and Sravanya Gavini and Dobs, {Adrian S}",
year = "2007",
month = "6",
doi = "10.1016/j.ecl.2007.03.014",
language = "English (US)",
volume = "36",
pages = "333--348",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Male Hypogonadism in Systemic Disease

AU - Kalyani, Rita R.

AU - Gavini, Sravanya

AU - Dobs, Adrian S

PY - 2007/6

Y1 - 2007/6

N2 - Hypogonadism is often observed in the presence of common acute and chronic illnesses in men. Low testosterone levels in these patients can be associated with loss of lean body mass and bone mass density, decline in mood, loss of energy, and sexual dysfunction. The mechanisms explaining hypogonadism and various systemic diseases are not completely understood, but these conditions are likely caused by a combination of stress, nonspecific weight loss, inflammation, and medication. Testosterone replacement can be considered in this population to improve lean body mass, bone mass density, and quality of life. More information is needed regarding the risk benefits of testosterone treatment on health outcomes in men who have systemic illness.

AB - Hypogonadism is often observed in the presence of common acute and chronic illnesses in men. Low testosterone levels in these patients can be associated with loss of lean body mass and bone mass density, decline in mood, loss of energy, and sexual dysfunction. The mechanisms explaining hypogonadism and various systemic diseases are not completely understood, but these conditions are likely caused by a combination of stress, nonspecific weight loss, inflammation, and medication. Testosterone replacement can be considered in this population to improve lean body mass, bone mass density, and quality of life. More information is needed regarding the risk benefits of testosterone treatment on health outcomes in men who have systemic illness.

UR - http://www.scopus.com/inward/record.url?scp=34249304431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249304431&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2007.03.014

DO - 10.1016/j.ecl.2007.03.014

M3 - Article

C2 - 17543722

AN - SCOPUS:34249304431

VL - 36

SP - 333

EP - 348

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 2

ER -